Skip to main content

Advertisement

Figure 5 | BMC Infectious Diseases

Figure 5

From: Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study

Figure 5

Odds Ratio (OR) of having suppressed HIV-RNA (<500 copies/ml) during more than 90% of time spent on cART. Multivariable model was also adjusted for: gender, age, race, risk factor for HIV acquisition, hepatitis B/C status, type of cART regimen, being ART naïve at initiation of cART, year of cART initiation, baseline CD4-cell count and HIV-RNA. SE, Southern Europe: Greece, Israel, Italy, Portugal, Spain; WCE, West Central Europe: Austria, Belgium, France, South Germany, Luxembourg, Switzerland; NE, Northern Europe: Denmark, Finland, North Germany, Ireland, the Netherlands, Norway, Sweden, the United Kingdom; ECE, East Central Europe: Bulgaria, Croatia, the Czech Republic, Hungary, Poland, Romania, Serbia and Slovakia; EE, Eastern Europe: Belarus, Estonia, Latvia, Lithuania, the Russian Federation and the Ukraine; AR, Argentina. cART, combination antiretroviral therapy; HIV-RNA, viral load.

Back to article page